Literature DB >> 27998046

Supervised exercise therapy: it does work, but how to set up a program?

David Hageman1,2,3, Marijn M van den Houten1,2,3, Steffie Spruijt3, Lindy N Gommans1,3, Marc R Scheltinga4, Joep A Teijink5,2,3.   

Abstract

Intermittent claudication (IC) is a manifestation of peripheral arterial disease. IC has a high prevalence in the older population, is closely associated with other expressions of atherosclerotic disease and often co-exists in multimorbid patients. Treatment of IC should address reduction of cardiovascular risk and improvement of functional capacity and health-related quality of life (QoL). As recommended by contemporary international guidelines, the first-line treatment includes supervised exercise therapy (SET). In several randomized controlled trials and systematic reviews, SET is compared with usual care, placebo, walking advice and endovascular revascularization. The evidence supporting the efficacy of SET programs to alleviate claudication symptoms is robust. SET improves walking distance and health-related QoL and appears to be the most cost-effective treatment for IC. Nevertheless, only few of all newly diagnosed IC patients worldwide receive this safe, efficient and structured treatment. Worldwide implementation of structured SET programs is seriously impeded by outdated arguments favoring an invasive intervention, absence of a network of specialized physical therapists providing standardized SET and lack of awareness and/or knowledge of the importance of SET by referring physicians. Besides, misguiding financial incentives and lack of reimbursement hamper actual use of SET programs. In the Netherlands, a national integrated care network (ClaudicatioNet) was launched in 2011 to combat treatment shortcomings and stimulate cohesion and collaboration between stakeholders. This care intervention has resulted in optimized quality of care for all patients with IC.

Entities:  

Mesh:

Year:  2016        PMID: 27998046     DOI: 10.23736/S0021-9509.16.09825-6

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  4 in total

Review 1.  Peripheral arterial disease: Scoping review of patient-centred outcomes.

Authors:  Laura Bolton
Journal:  Int Wound J       Date:  2019-10-09       Impact factor: 3.315

2.  Protocol for a prospective, longitudinal cohort study on the effect of arterial disease level on the outcomes of supervised exercise in intermittent claudication: the ELECT Registry.

Authors:  Marijn Ml van den Houten; Sandra Cp Jansen; Anneroos Sinnige; Lijckle van der Laan; Patrick Whe Vriens; Edith M Willigendael; Jan-Willem Hp Lardenoije; Jan-Willem M Elshof; Eline S van Hattum; Maarten A Lijkwan; Ivan Nyklíček; Ellen V Rouwet; Mark Jw Koelemay; Marc Rm Scheltinga; Joep Aw Teijink
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

3.  Adherence to Guideline-Recommended Therapy-Including Supervised Exercise Therapy Referral-Across Peripheral Artery Disease Specialty Clinics: Insights From the International PORTRAIT Registry.

Authors:  John T Saxon; David M Safley; Carlos Mena-Hurtado; Jan Heyligers; Robert Fitridge; Mehdi Shishehbor; John A Spertus; Kensey Gosch; Manesh R Patel; Kim G Smolderen
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

4.  Cross-sectoral rehabilitation intervention for patients with intermittent claudication versus usual care for patients in non-operative management - the CIPIC Rehab Study: study protocol for a randomised controlled trial.

Authors:  Maj Siercke; Lise Pyndt Jørgensen; Malene Missel; Lau Caspar Thygesen; Pernille Peppercorn Blach; Henrik Sillesen; Selina Kikkenborg Berg
Journal:  Trials       Date:  2020-01-21       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.